iPSC drug Development summit
The 5th Annual iPSC Drug Development Summit returns to Boston as your longest standing and most definitive platform for uniting iPSC-based drug developers across the value chain, from R&D right through to CMC, to accelerate the development of genetically stable, clinically efficacious and scalable iPSC cell therapies.
Tailor your learning across 2 tracks of content, with a Preclinical stream, and Process Development & CMC stream – dive into novel humanized mouse models to aid a greater translational leap into the clinic, or explore novel bioreactors for new methods of iPSC generation.
The 5th Annual iPSC Drug Development Summit returns to Boston as your longest standing and most definitive platform for uniting iPSC-based drug developers across the value chain, from R&D right through to CMC, to accelerate the development of genetically stable, clinically efficacious and scalable iPSC cell therapies.
Tailor your learning across 2 tracks of content, with a Preclinical stream, and Process Development & CMC stream – dive into novel humanized mouse models to aid a greater translational leap into the clinic, or explore novel bioreactors for new methods of iPSC generation.
We are sponsoring this event!
bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant and highly characterised, offering predictive, in vitro, human cells for early drug discovery, phenotypic screening and high-content imaging applications. Come and meet Kam Dhaliwal, SVP Strategic Alliances to learn more.
Arrange a meeting